Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 8,281–8,340 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

University of Milano-Bicocca1 University of Minnesota Advanced Research Diagnostic Laboratory1 University of Montreal1 University of Muenster1 University of Nebraska Medical Centre1 University of New Brunswick1 University of Newcastle HREC1 University of Newcastle upon Tyne1 University of Nigeria Teaching Hospital1 University of North Carolina IUCAC1 University of North Carolina Thurston Arthritis Research Center1 University of North Carolina at Chapel Hill Institutional Review Board1 University of Notre Dame Australia1 University of Oklahoma1 University of Oklahoma Health Sciences Center1 University of Oldenburg1 University of Osaka Hospital1 University of Oslo1 University of Ottawa Heart Institute1 University of Ottawa Research Ethics Board1 University of Padua1 University of Perugia1 University of Pittsburgh Medical Center1 University of Pittsburgh School of Medicine1 University of Pécs1 University of Rwanda1 University of San Carlos–Extension1 University of Santo Amaro1 University of Saskatchewan1 University of Social Welfare and Rehabilitation Sciences1 University of Sorocaba1 University of South Australia1 University of South Australia HREC1 University of South China1 University of Southern California Keck School of Medicine1 University of Stirling1 University of São Paulo1 University of Texas MD Anderson Cancer Center1 University of Texas Physicians1 University of Texas at Austin1 University of Texas – Houston1 University of Tokyo1 University of Toronto Lupus Clinic1 University of Tsukuba Hospital1 University of Turin1 University of Ulm1 University of Utah Heritage 1000 Projects1 University of Vermont1 University of Vermont Institutional Review Board1 University of Verona1 University of Victoria1 University of Virginia Flow Cytometry Core1 University of Warwick1 University of Winchester1 University of Wisconsin Carbone Cancer Center1 University of Wisconsin Carbone Cancer Centre1 University of Wisconsin Institutional Animal Care and Use Committee1 University of Wisconsin Institutional Review Board1 University of Wolverhampton1 University of Würzburg1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 310 of 946

376 Harnessing sentinel lymph nodes for adoptive cell therapy in head and neck squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

93.4%

University of California San Diego Gleiberman Head and Neck Cancer Center Head and neck squamous cell carcinoma (HNSCC)tdRT_SLN tdRT Adoptive cell therapy HNSCC

… Institutional Animal Care and Use Committee of UCSD (#S16200), University of California San Diego. The study was conducted in accordance with the local legislati…

379 Selection of CD103+CD31-CD8+ cells enriches tumor reactivity of tumor infiltrating lymphocytes (TIL) independent of personalized sequencing

jitc · abstract · 2025-11-04 · 2 matching annotations

87.0%

National Institutes of Health NIH IL-2 melanomas epithelial cancers gastrointestinal cancers

…;370(6522):1328-1334.Ethics Approval This study was approved by National Institutes of Health (NIH) Internal Review Board (IRB); approval number NCT00068003.…

382 Improved ex vivo expansion of tumour-infiltrating lymphocytes from gynaecological cancer biopsies using dendritic cells derived from the leukemic cell line DCOne

jitc · abstract · 2025-11-04 · 2 matching annotations

84.7%

UMCG N. Engl. J. Med.metastatic melanoma ipilimumab IL-2 IL-2-based solid tumours endometrial cancer metastatic ovarian cancer Adoptive cell therapy+1 more

…iative has been approved by the medical ethics committee of the UMCG (no. 2010/109) and has been ISO certified (9001:2008 Healthcare…

396 Decoding and targeting the CMML antigenic landscape with novel, highly effective multi-epitope specific cytotoxic CD4+ T cells

jitc · abstract · 2025-11-04 · 2 matching annotations

85.3%

NCT02775383 National MDS Natural History Study biobank chronic myelomonocytic leukemia (CMML)hypomethylating agents Adoptive T-cell therapy allogeneic stem cell transplantation

…ofiling on bone marrow cells from CMML/MDS MPN patient cohort ( NCT02775383) obtained from the National MDS Natural History Study biobank a…

40 Blood-based proteomic and glycoproteomic biomarkers exhibit promising additivity in predicting response in checkpoint inhibitor treated lung cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.4%

Translational Immunology Laboratory University of Sydney Pembrolizumab lung cancer Durvalumab Nivolumab The University of Sydney Ethics Board

…and n=29 ICI+chemo). Pre-treatment samples were provided by the Translational Immunology Laboratory at the University of Sydney. The cohort consisted of 21 males a…

420 Immune checkpoint blockade of PSGL-1 overcomes resistance to anti-PD-1 treatment in melanoma by enhancing effector T cell differentiation

jitc · abstract · 2025-11-04 · 2 matching annotations

92.1%

Sanford Burnham Prebys PSGL-1 melanoma tumors The NIH Shared Instrumentation Grant S10OD032325 PSGL1

…32325 for the Cytek Aurora housed in the Flow Cytometry Core at Sanford Burnham Prebys.References 1.Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB…

430 Clonal diversification reshapes the exhaustion landscape of tumor-infiltrating T cells following immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

81.2%

mouse tumor model AbbVie ICI colorectal tumors anti-CD40 agonist antibody human cancer types T cell exhaustion

…we performed a longitudinal analysis using serial biopsies from mouse tumor model treated with ICI and exhibiting differential responses, integra…

434 Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent or metastatic nasopharyngeal carcinoma: a real-world study

jitc · abstract · 2025-11-04 · 2 matching annotations

90.3%

The First Affiliated Hospital of Nanchang University Sun Yat-sen University Cancer Center Institutional Review Board locoregional therapy ICI rechallenge recurrent or metastatic nasopharyngeal carcinoma (RM-NPC)

…his study is supported by Clinical Research Training Project of The First Affiliated Hospital of Nanchang University (No. YFYLCYJPY202444) and Science and Technology Project of Hea…

436 Immune checkpoint inhibitors in sinonasal squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

96.0%

USC Norris Comprehensive Cancer Center Los Angeles General Medical Center pembrolizumab cetuximab Sinonasal malignancies squamous cell carcinoma SNSCC

…rapy for histologically confirmed recurrent/metastatic SNSCC at USC Norris Comprehensive Cancer Center and Los Angeles General Medical Center (LAGMC) from 2016 to 202…

441 Reimagining bladder cancer immunotherapy: local non-viral gene delivery of DNA-encoded immune checkpoint inhibitors

jitc · abstract · 2025-11-04 · 2 matching annotations

80.4%

C57BL/6 mice nivolumab pembrolizumab detalimogene voraplasmid DDX

…duration, dose response, and systemic exposure were assessed in C57BL/6 mice after IVI. A custom paratope-specific immunoassay on the Meso S…

448 The brain tissue environment contributes to a unique response of glioblastoma against immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

78.7%

National Cancer Institute Eur J Clin Invest NOX-A12 Glioblastoma GBM ICB immunotherapy ICB

… animal experiments and protocols were reviewed and approved by National Cancer Institute…

449 SUSD2 augments antitumor immunity by targeting TRAF2/NF-κB/CXCL1 axis in lung adenocarcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

90.7%

TCGA-LUAD TCGA lung adenocarcinoma SUSD2 Immune checkpoint blockades syngeneic tumors

…th the overall survival of patients with lung adenocarcinoma in TCGA-LUAD (figure 1C-D). Knockdown of SUSD2 significantly promoted tumor …